Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 (original) (raw)
- Short Communication
- Published: 26 March 2007
- T Takeuchi1 na1,
- E Nishikawa1 na1,
- K Yanagisawa1,
- Y Hayashita3,
- H Ebi1,
- H Yamada1,2,
- M Suzuki1,
- M Nagino2,
- Y Nimura2,
- H Osada3 &
- …
- T Takahashi1
Oncogene volume 26, pages 6099–6105 (2007)Cite this article
- 3198 Accesses
- 289 Citations
- 17 Altmetric
- Metrics details
Abstract
Amplification and overexpression of the miR-17-92 microRNAs (miRNA) cluster at 13q31.3 has recently reported, with pointers to functional involvement in the development of B-cell lymphomas and lung cancers. In the present study, we show that inhibition of miR-17-5p and miR-20a with antisense oligonucleotides (ONs) can induce apoptosis selectively in lung cancer cells overexpressing miR-17-92, suggesting the possibility of ‘OncomiR addiction’ to expression of these miRNAs in a subset of lung cancers. In marked contrast, antisense ONs against miR-18a and miR-19a did not exhibit such inhibitory effects, whereas inhibition of miR-92-1 resulted in only modest reduction of cell growth, showing significant distinctions among miRNAs of the miR-17-92 cluster in terms of their roles in cancer cell growth. During the course of this study, we also found that enforced expression of a genomic region, termed C2, residing 3′ to miR-17-92 in the intron 3 of C13orf25 led to marked growth inhibition in association with double stranded RNA-dependent protein kinase activation. Finally, this study also revealed that the vast majority of C13orf25 transcripts are detected as Drosha-processed cleavage products on Northern blot analysis and that a novel polyadenylation site is present 3′ to the miR-17-92 cluster and 5′ to the C2 region. Taken together, the present findings contribute towards better understanding of the oncogenic roles of miR-17-92, which might ultimately lead to the future translation into clinical applications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Ambros V . (2004). The functions of animal microRNAs. Nature 431: 350–355.
Article CAS PubMed Google Scholar - Bartel DP . (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.
Article CAS PubMed Google Scholar - Bommer UA, Borovjagin AV, Greagg MA, Jeffrey IW, Russell P, Laing KG et al. (2002). The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. RNA 8: 478–496.
Article CAS PubMed PubMed Central Google Scholar - Cullen BR . (2004). Transcription and processing of human microRNA precursors. Mol Cell 16: 861–865.
Article CAS PubMed Google Scholar - Esquela-Kerscher A, Slack FJ . (2006). Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 6: 259–269.
Article CAS PubMed Google Scholar - Gil J, Esteban M . (2000). Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5: 107–114.
Article CAS PubMed Google Scholar - Gleave ME, Monia BP . (2005). Antisense therapy for cancer. Nat Rev Cancer 5: 468–479.
Article CAS PubMed Google Scholar - Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628–9632.
Article CAS PubMed Google Scholar - He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435: 828–833.
Article CAS PubMed PubMed Central Google Scholar - Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635–647.
Article CAS PubMed Google Scholar - Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438: 685–689.
Article PubMed Google Scholar - Macleod K . (1999). pRb and E2f-1 in mouse development and tumorigenesis. Curr Opin Genet Dev 9: 31–39.
Article CAS PubMed Google Scholar - Maeno K, Masuda A, Yanagisawa K, Konishi H, Osada H, Saito T et al. (2006). Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers. Oncogene 25: 271–277.
Article CAS PubMed Google Scholar - Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG . (1993). Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90: 232–236.
Article CAS PubMed PubMed Central Google Scholar - O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839–843.
Article PubMed Google Scholar - Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. (2004). Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087–3095.
Article CAS PubMed Google Scholar - Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753–3756.
Article CAS PubMed Google Scholar - Zamore PD, Haley B . (2005). Ribo-gnome: the big world of small RNAs. Science 309: 1519–1524.
Article CAS PubMed Google Scholar - Zarudnaya MI, Kolomiets IM, Potyahaylo AL, Hovorun DM . (2003). Downstream elements of mammalian pre-mRNA polyadenylation signals: primary, secondary and higher-order structures. Nucleic Acids Res 31: 1375–1386.
Article CAS PubMed PubMed Central Google Scholar
Acknowledgements
We thank Dr Yoshitaka Sekido at Aichi Cancer Center for his warm support during the course of this study. This work was financially supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Grain-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science.
Author information
Author notes
- H Matsubara, T Takeuchi and E Nishikawa: These authors contributed equally to this work.
Authors and Affiliations
- Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan,
H Matsubara, T Takeuchi, E Nishikawa, K Yanagisawa, H Ebi, H Yamada, M Suzuki & T Takahashi - Department of Surgical Oncology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan,
H Matsubara, H Yamada, M Nagino & Y Nimura - Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
Y Hayashita & H Osada
Authors
- H Matsubara
You can also search for this author inPubMed Google Scholar - T Takeuchi
You can also search for this author inPubMed Google Scholar - E Nishikawa
You can also search for this author inPubMed Google Scholar - K Yanagisawa
You can also search for this author inPubMed Google Scholar - Y Hayashita
You can also search for this author inPubMed Google Scholar - H Ebi
You can also search for this author inPubMed Google Scholar - H Yamada
You can also search for this author inPubMed Google Scholar - M Suzuki
You can also search for this author inPubMed Google Scholar - M Nagino
You can also search for this author inPubMed Google Scholar - Y Nimura
You can also search for this author inPubMed Google Scholar - H Osada
You can also search for this author inPubMed Google Scholar - T Takahashi
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toT Takahashi.
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Matsubara, H., Takeuchi, T., Nishikawa, E. et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.Oncogene 26, 6099–6105 (2007). https://doi.org/10.1038/sj.onc.1210425
- Received: 06 December 2006
- Revised: 06 February 2007
- Accepted: 08 February 2007
- Published: 26 March 2007
- Issue Date: 06 September 2007
- DOI: https://doi.org/10.1038/sj.onc.1210425